LANADELUMAB-FLYO for Immune system disorder: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 327 adverse event reports in the FDA FAERS database where LANADELUMAB-FLYO was used for Immune system disorder.
Most Reported Side Effects for LANADELUMAB-FLYO
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Hereditary angioedema | 794 | 53.2% | 13 | 311 |
| Product dose omission issue | 177 | 11.9% | 4 | 92 |
| Inappropriate schedule of product administration | 144 | 9.7% | 3 | 66 |
| Drug ineffective | 137 | 9.2% | 3 | 48 |
| Headache | 126 | 8.4% | 3 | 39 |
| Weight decreased | 125 | 8.4% | 1 | 71 |
| Weight increased | 120 | 8.0% | 3 | 72 |
| Injection site pain | 119 | 8.0% | 0 | 33 |
| Product use issue | 114 | 7.6% | 1 | 56 |
| Malaise | 90 | 6.0% | 3 | 41 |
| Nausea | 77 | 5.2% | 0 | 32 |
| Stress | 77 | 5.2% | 1 | 41 |
| Dizziness | 76 | 5.1% | 1 | 27 |
| Pain | 75 | 5.0% | 2 | 31 |
| No adverse event | 73 | 4.9% | 0 | 0 |
Other Indications for LANADELUMAB-FLYO
Product used for unknown indication (569)
Hereditary angioedema (559)
Hereditary angioedema with c1 esterase inhibitor deficiency (46)
Angioedema (34)
Prophylaxis (34)
Hereditary angioedema with normal c1 esterase inhibitor (19)
Other Drugs Used for Immune system disorder
LANADELUMAB (1,047)
ICATIBANT (847)
HUMAN IMMUNOGLOBULIN G (508)
HUMAN C1-ESTERASE INHIBITOR (387)
ECALLANTIDE (132)
RITUXIMAB (77)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE (51)
LENALIDOMIDE (46)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (35)
RUXOLITINIB (35)